Watch Ticker

Acumen Pharmaceuticals, Inc. Common Stock

Go to Acumen Pharmaceuticals, Inc. Common Stock Website

$1.36

0.03 (2.26%)

Live

Previous Close

$1.36

Day Range

$1.31 - $1.41

Previous Day Range

$1.29 - $1.39

Market Cap

$80.6 million USD

Day Vol.

312414

Previous Day Vol.

176190

Currency

USD

Primary Exchange

Nasdaq

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Acumen Pharmaceuticals - Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025

Acumen Pharmaceuticals will report Q2 2025 financial results on August 12, 2025, and host a conference call to provide a business and financial update, focusing on their Alzheimer's disease therapeutic candidate sabirnetug.

Related tickers: ABOS, HALO.

Read Full Article

Acumen Pharmaceuticals - Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at the Alzheimer’s Association International Conference (AAIC®) 2025

Acumen Pharmaceuticals will present research on cost savings and drug selectivity for sabirnetug, a potential Alzheimer's disease treatment, at the Alzheimer's Association International Conference in Toronto in July 2025.

Related tickers: ABOS.

Read Full Article

Trending Tickers

Please sign in to view